Petco Health & Wellness Company, Inc. (WOOF) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-08-01..
- Stock-based compensation / revenue · 12 months: Value 0.54%; Formula and calculation Share-based compensation / revenue. Period ending 2026-08-01..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-08-01; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-08-01. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.54% | Share-based compensation / revenue. Period ending 2026-08-01. $32.49M ÷ $5.97B × 100 ≈ 0.54% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 5.97B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 32.49M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 133.49M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 | (m) | $5.97B | $32.49M | $133.49M | (m) | (m) | 0.54% | (m) | (m) |
| 2026-05-02 | (m) | $5.96B | $32.68M | $128.70M | (m) | (m) | 0.55% | (m) | (m) |
| 2026-01-31 | (m) | $5.96B | $32.65M | $120.43M | (m) | (m) | 0.55% | (m) | (m) |
| 2025-11-01 | (m) | $6.00B | $34.88M | $105.97M | (m) | (m) | 0.58% | (m) | (m) |
| 2025-08-02 | (m) | $6.05B | $39.07M | $80.75M | (m) | (m) | 0.65% | (m) | (m) |
| 2025-05-03 | (m) | $6.08B | $42.20M | $40.19M | (m) | (m) | 0.69% | (m) | (m) |
| 2025-02-01 | (m) | $6.12B | $50.21M | $7.05M | (m) | (m) | 0.82% | (m) | (m) |
| 2024-11-02 | (m) | $6.24B | $58.13M | $-10.17M | (m) | (m) | 0.93% | (m) | (m) |
| 2024-08-03 | (m) | $6.22B | $64.96M | $-1.25B | $149.84M | (m) | 1.04% | -8.32× | Reported |
| 2024-05-04 | (m) | $6.23B | $77.16M | $-1.22B | $150.52M | (m) | 1.24% | -8.14× | Reported |
| 2024-02-03 | (m) | $6.26B | $81.86M | $-1.18B | $150.91M | (m) | 1.31% | -7.82× | Reported |
| 2023-10-28 | (m) | $6.16B | $84.32M | $-1.10B | $144.13M | (m) | 1.37% | -7.65× | Reported |
| 2023-07-29 | (m) | $6.17B | $81.92M | $177.27M | $134.88M | (m) | 1.33% | 1.31× | Reported |
| 2023-04-29 | (m) | $6.12B | $70.69M | $203.24M | $119.21M | (m) | 1.16% | 1.70× | Reported |
| 2023-01-28 | (m) | $6.04B | $60.78M | $225.56M | $101.64M | (m) | 1.01% | 2.22× | Reported |
| 2022-10-29 | (m) | $5.97B | $53.67M | $230.90M | $87.65M | (m) | 0.90% | 2.63× | Reported |
| 2022-07-30 | (m) | $5.91B | $51.27M | $244.80M | $79.12M | (m) | 0.87% | 3.09× | Reported |
| 2022-04-30 | (m) | $5.87B | $49.88M | $268.26M | $76.50M | (m) | 0.85% | 3.51× | Reported |
| 2022-01-29 | (m) | $5.81B | $49.27M | $266.07M | $77.40M | (m) | 0.85% | 3.44× | Reported |
| 2021-10-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-05-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-30 | (m) | $4.92B | $12.91M | $194.42M | $219.08M | (m) | 0.26% | 0.89× | Reported |
| 2020-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-08-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-05-02 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-02-01 | (m) | $4.43B | $9.49M | $110.60M | $253.02M | (m) | 0.21% | 0.44× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.